Downloads
Article: A Focus On The Science And The Business
By James Netterwald, Ph.D.
RXi Pharmaceuticals was founded by one of the codiscoverers of the RNAi mechanism and recent Nobel laureate Craig Mello, Ph.D., professor of molecular medicine at University of Massachusetts. Dr. Mello is still a member of the company's scientific advisory board. RXi officially began operations in 2007 after it was spun off by its parent company CytRx Pharmaceuticals, which still maintains an approximately 39% interest in RXi.
Used with permission from Life Science Leader magazine.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get access to this piece of content and thousands of additional articles and product reviews across our entire network of sites.
